Protalix BioTherapeutics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Protalix BioTherapeutics, Inc. (PLX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.12 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-03-06
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was $4.00K.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-09-30 was -$169.00K.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was -$248.00K.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was -$99.00K.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$1.12M.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$967.00K.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$512.00K.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$1.00M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$1.12M 10-K · filed 2018-03-06 | |||
| 2016-12-31 | -$967.00K 10-K · filed 2018-03-06 | |||
| 2015-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$165.00K derived: sum of 2 quarters · filed 2018-03-06 | -$413.00K derived: sum of 3 quarters · filed 2018-03-06 | -$512.00K 10-K · filed 2018-03-06 |
| 2015-09-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$417.00K derived: sum of 2 quarters · filed 2015-11-09 | -$516.00K 10-Q · filed 2015-11-09 | -$685.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$347.00K 10-Q · filed 2015-08-10 | -$516.00K derived: sum of 3 quarters · filed 2017-03-16 | -$783.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$99.00K 10-Q · filed 2015-05-07 | -$268.00K derived: sum of 2 quarters · filed 2017-03-16 | -$535.00K derived: sum of 3 quarters · filed 2017-03-16 | -$730.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | -$169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$436.00K derived: sum of 2 quarters · filed 2017-03-16 | -$631.00K derived: sum of 3 quarters · filed 2017-03-16 | -$1.00M 10-K · filed 2017-03-16 |
| 2014-09-30 | -$267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$462.00K derived: sum of 2 quarters · filed 2015-11-09 | -$832.00K 10-Q · filed 2015-11-09 | -$1.10M derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$565.00K 10-Q · filed 2015-08-10 | -$836.00K derived: sum of 3 quarters · filed 2016-03-08 | -$1.25M derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | -$370.00K 10-Q · filed 2015-05-07 | -$641.00K derived: sum of 2 quarters · filed 2016-03-08 | -$1.06M derived: sum of 3 quarters · filed 2016-03-08 | -$1.78M derived: sum of 4 quarters · filed 2016-03-08 |
| 2013-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$690.00K derived: sum of 2 quarters · filed 2016-03-08 | -$1.41M derived: sum of 3 quarters · filed 2016-03-08 | -$2.10M 10-K · filed 2016-03-08 |
| 2013-09-30 | -$419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$1.14M derived: sum of 2 quarters · filed 2014-11-10 | -$1.83M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$723.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$1.41M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$689.00K 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | -$2.29M 10-K · filed 2015-03-12 | |||
| 2011-12-31 | -$5.87M 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |